$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
New 10-year data shows ibrutinib/Eco has durable efficacy in CLL/SLL
2026-02-01 22:25:32
Check Details
INCB057643 combined with ruxolitinib tablets/ruxolitinib can improve symptoms in patients with myelofibrosis
2026-02-01 22:25:32
Check Details
How long does it take for the skin color to return to its original color after stopping taking Clofazimine/Sempra?
2026-02-01 22:25:32
Check Details
How much does a single bottle of Enasidenib cost in RMB?
2026-02-01 22:25:32
Check Details
Evantumumab/Carestream combination significantly improves OS in Asian EGFR+ non-small cell lung cancer population
2026-02-01 22:25:32
Check Details
What important information does the detailed instructions for acotinib/cancostat contain?
2026-02-01 22:25:32
Check Details
Does ibrutinib/Eco need to be taken for a long time? What are the recommendations?
2026-02-01 22:25:32
Check Details
Is Ruxolitinib Tablets/Jiekewei a targeted drug?
2026-02-01 22:25:32
Check Details
How to prevent skin darkening while taking clofazimine/sempra
2026-02-01 22:25:32
Check Details
Analysis of the main efficacy and clinical effects of Enasidenib
2026-02-01 22:25:32
Check Details
The price of amivantamab in 2025
2026-02-01 22:25:32
Check Details
Is acotinib/cancostat a targeted drug?
2026-02-01 22:25:32
Check Details
1
2
...
2025
2026
2027
2028
2029
2030
2031
...
10240
10241
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Ponatinib in the PACE Phase II Trial: Response Data in Resistant CML and Ph+ ALL
2
Selumetinib for NF1-Related Plexiform Neurofibromas: Time to Response and Response Assessment
3
How to Take Tucatinib (Tukysa): Dosing Schedule, Combination Use & Missed Dose Guidance
4
Ganaxolone Common Side Effects: Somnolence, Sedation and Safety Notes
5
Baxdrostat: Efficacy and Safety of a Novel Aldosterone Synthase Inhibitor
6
Anamorelin (ADLUMIZ): GHS-R1a Agonist for Cancer Cachexia—Mechanism, Use, and Safety Boundaries
7
Vemurafenib Mechanism and Clinical Indications: BRAF V600E Mutant Melanoma and ECD Treatment
8
Anagrelide Cautions and Contraindications: Allergy, Hepatic, Cardiac and Bleeding Risks
9
FDA Accelerated Approval of Voceryq: First Plasmid DNA Immunotherapy for Adult Recurrent Respiratory Papillomatosis
10
Ribociclib: Mechanism of Action and Approved Uses in Breast Cancer
11
Revumenib: Key Considerations Before and During Treatment
12
Pacritinib in Myelofibrosis: Evidence on Spleen Volume Reduction and Symptom Control